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Effect of Toxaphene on Pyruvic and
Lactic Acid Levels in the Rat
by David B. Peakall*
Rats were given a single dose oftoxaphene (120mg/kgequivalent to 1/2 LD50) and sacrificed at 1,5, and
15 days. No alterations of levels of pyruvic or lactic acid in blood plasma were observed. In a second
experiment, rats were given 2.4 mg/kgdaily and sacrificed at 1, 3, and 6 months, and again no alterations
ofpyruvic or lactic acid levels were found. It is concluded that observed alterations ofthe activity oflactic
acid dehydrogenase induced by toxaphene do not give rise to physioogical changes in unstressed rats.
Introduction
Recent studies (1, 2) have shown that the activity
of the enzyme lactate dehydrogenase (LDH) is de-
creased in the blood serum, liver, and kidneys of
rats exposed to toxaphene. In this paper the
physiological consequences of these alterations are
examined by determining the levels of pyruvic and
lactic acids in the serum ofrats exposed to the same
regime oftoxaphene as used by Kuz'minskaya and
Alekhina (1).
Materials and Methods
The experiments were divided into two sections,
short-term and chronic administration. In the
short-term experiments, male rats were given tox-
aphene orally by capsule as a single dose of1/2 LD50
(120 mg/kg), and animals sacrificed at 1, 5, and 15
days. In the chronic experiments the animals were
fed 1/100 LD50 daily for 1, 3, and 6 months. At sac-
rifice, blood samples were taken and the liver re-
moved for analysis. Levels of lactate and pyruvate
were measured spectrophotometrically in depro-
teinized blood by the method ofOlsen (3). Levels of
toxaphene in the liver were determined by gas-
liquid chromatography by using the method of Wil-
son (4).
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Results
The basic results of the experiments are given in
Table 1. No significant alteration of either pyruvic
or lactic acids were found either in the short-term
single dose experiments nor in the chronic, daily
dose animals. The levels found in blood are similar
to those reported to other workers (5, 6). The res-
idue data indicated that equilibrium in the liver had
been reached within one month on dosage and that
equilibrium levels in the brain were reached within
one to three months.
Discussion
The work ofGertig and Nowaczyk (2) and that of
Kuz'minskaya and Alekhina (1) showed that tox-
aphene does alter the activity of the enzyme lactic
dehydrogenase. The results presented here indicate
that this alteration is not enough to have definite
physiological consequences under the conditions of
the experiment. The major importance oflactic acid
is in its conversion to glycogen when the animal is in
oxygen debt following exertion. This process is
outlined in Figure 1. A criticism ofthe current study
is that it was not carried out under the stress of
exercise. The pyruvate-lactate shunt (see Fig. 2) is
more important under conditions ofexcessive exer-
cise and presumably under these conditions the
capacity ofthe enzyme system would be more fully
extended. Under normal conditions, it appears that
either there is enough reserve capacity in the en-
zyme system of the pyruvate-lactate shunt, or that
June 1979 97Table 1. Effect of toxaphene on blood plasma levels of lactic and pyruvic acids.
Time on Level oftoxaphene, ppm wetweight Blood plasma levels, mg/100 mP
toxaphenea Liver Brain Lactic acid Pyruvic acid
1 day 2.3 ±0.4 (4) Not detected 7.7 ± 0.6 (6) 2.0 ± 0.2 (6)
5 days 4.2 ±1.8 (4) 2.0 ± 1.0 (4) 7.5 ± 0.6 (6) 1.8 ± 0.2 (6)
15 days 5.7 ±2.3 (4) 2.7 ± 1.4 (4) 8.1 ± 0.6 (6) 2.1 ± 0.3 (6)
1 month 27.7 ±2.3 (4) 9.3 ± 1.1 (4) 7.3 ± 0.7 (6) 2.2 ±0.3 (6)
3 months 26.4 ± 1.7 (4) 12.7 ± 1.5 (4) 7.5 ± 0.6 (6) 1.9 0.2 (6)
6 months 25.7 ±2.1 (4) 12.0 +- 1.3 (4) 8.2 ±0.8 (6) 2.1 ±0.3 (6)
a 1-15 day animals were exposed to a single dose of 120 mg/kg; 1-6 month animals were given 2.4 mg/kg daily.
b Mean, standard deviation, and sample size.
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FIGURE 1. Overall utilization of lactic acid during exercise.
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FIGURE 2. Metabolic pathways involving pyruvic and lactic
acids.
with a complex, interrelated system (Fig. 2) alter-
ations in one part ofthe system can be compensated
for by alterations in other pathways.
Bhatia et al. (5) found that a single sublethal dose
of dieldrin (30 mg/kg, CV, equivalent to 65% of
LD50) caused significant increase of the levels of
pyruvic and lactic acids 20-24 hr after injection.
These authors consider that these changes could be
due to inhibition of pyruvate oxidation or to in-
crease demand due to the stimulation of hepatic
glucose. In contrast, the results given here show
that a single, sublethal dose of toxaphene does not
act similarly to dieldrin.
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